ArticleBMC medical education2025
Former access to medicine higher education diploma students' experiences of their diploma course and subsequent professional degree: a qualitative study.
Article in BMC medical education, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionAccess to Higher Education Diplomas (Medicine) are courses offered at UK Further Education colleges for mature students who lack the qualifications required to study medicine, dentistry or pharmacy). These courses are frequently referred to as Access to Medicine Courses (ATMCs) and provide students with the necessary entry level qualification to study these subjects at university. ATMCs play a role in efforts to widen participation in medicine for non-traditional students. However, relatively little is known about the experiences of former ATMC students during their course, professional degrees and early careers. This study investigates the experiences of former ATMC students who are practising doctors or pharmacists with a focus on decision-making surrounding the ATMC, positive and negative experiences resulting from being an ATMC student both before and after qualification, and their views and experiences of widening participation (WP).
methodFifteen participants who had graduated from medicine or pharmacy after using an ATMC as their entry qualification were recruited using convenience and snowball sampling. Semi-structured interviews were conducted and the data analysed using thematic analysis.
resultsFourteen medical doctors and one pharmacist were interviewed. Ten participants were female and five male. Participants attended four ATMCs before studying at five universities. Nine participants could be classed as WP students. Interviews ranged from 30 to 75 min. Several themes and subthemes emerged from the analysis. The location of the course provider was a factor in ATMC choice. Reported disadvantages of ATMC were the limited number of medical schools accepting the qualification and deficiencies in chemistry. Advantages included supportive peers and tutors. Participants spoke about their experiences and views of WP and the role ATMC could play in it. Participants commented on the role that socioeconomic background and schools have in potential candidates aspiring to a career in medicine.
conclusionATMCs are crucial in efforts to widen participation in medicine, pharmacy and dentistry. There are issues with the courses that need to be addressed especially in how well they prepare students for medical school in chemistry. This research suggests that addressing shortcomings in potential candidates' aspirations due to their socioeconomic backgrounds and schooling would increase the number of people applying to medical school from non-traditional backgrounds.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.